The NeuMeDx mission is to advance the frontiers of noninvasive hemodynamic monitoring, by distributing cost-effective, cutting-edge technologies that improve the safety of hemodynamic monitoring, increase diagnostic accuracy and provide the foundation for protocol-driven medicine and earlier goal-directed therapy.
The PhysioFlow® family of products, with its patented Signal-Morphology Impedance Cardiography (SM-ICG™) technology, is the first of a series of new technologies that NeuMeDx will be distributing to meet our mission.
